JPRN-UMIN000023741招募中未知
Stiripentol (diacomit(R)) for refractory epilepsy patients with autoimmune encephalitis - Stiripentol (diacomit(R)) for refractory epilepsy patients with autoimmune encephalitis
agoya City University0 个研究点目标入组 6 人开始时间: 2016年8月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patients allergic to component of this drug pregnant or possibly pregnant women patients chief or sub investigator diagnose inappropriate
研究者
相似试验
No Longer Available
不适用
Stiripentol in Dravet SyndromeDravet SyndromeNCT01533506Mayo Clinic
招募中
2 期
Stiripentol for the treatment of pharmacoresistant epilepsy with drug eruptionsPatients with pharmacoresistant epilepsy with drug eruptionsJPRN-UMIN000034986Department of Neurology, Nagoya City University20
已完成
2 期
Evaluation of the Efficacy of Stiripentol (Diacomit) as Monotherapy for the Treatment of Primary HyperoxaluriaPrimary HyperoxaluriaNCT03819647Biocodex15
已完成
不适用
Stiripentol for the Treatment of Refractory Status EpilepticusStatus EpilepticusNCT06540378University Hospital Marburg25
No Longer Available
不适用
Expanded Access Use of Stiripentol in Dravet Syndrome or Sodium Channel Mutation Epileptic EncephalopathiesDravet SyndromeEpileptic Encephalopathies Associated With SCN1A MutationsNCT02239276Cook Children's Health Care System